Should you buy Globus Medical (GMed) stock?
Investors are optimistic about Globus Medical (GMED), backed by strength in the Enabling Technologies arm and ExcelsiusGPS platforms. It hasn't been the best quarter for Globus Medical, Inc. ( NYSE:GMED ) shareholders, since the share price has fallen... Is Globus Medical a Great Stock to Buy Right Now?
What does GMed stand for?
Globus Medical, Inc. (NYSE:GMED), which is in the medical equipment business, and is based in United States, saw a... Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting Globus Medical, Inc. (GMED), a leading musculoskeletal solutions company, today announced the launch of the AUTOBAHN® Nailing System.
What's happening with global medical stock?
Global Medical (NYSE: GMED) is a medical device stock that faced its fair share of challenges during the earlier days of the pandemic and is slowly recovering its business growth.
Where can I buy GMed shares?
Shares of GMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
Is GMED a good stock to buy?
Out of 10 analysts, 6 (60%) are recommending GMED as a Strong Buy, 3 (30%) are recommending GMED as a Buy, 1 (10%) are recommending GMED as a Hold, 0 (0%) are recommending GMED as a Sell, and 0 (0%) are recommending GMED as a Strong Sell. What is GMED's earnings growth forecast for 2022-2024?
Is Globus Medical a good stock?
Globus Medical has received a consensus rating of Buy. The company's average rating score is 2.91, and is based on 10 buy ratings, 1 hold rating, and no sell ratings.
How do I buy Abcellera stock?
How to buy stocks in Abcellera Biologics IncCompare stock trading platforms. Use our comparison table to help you find a platform that fits you.Open your brokerage account. Complete an application with your details.Confirm your payment details. ... Research the stock. ... Purchase now or later. ... Check in on your investment.
Should I buy or sell Globus Medical stock right now?
10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last twelve months. There are cur...
What is Globus Medical's stock price forecast for 2022?
10 Wall Street analysts have issued 1-year target prices for Globus Medical's stock. Their forecasts range from $70.00 to $100.00. On average, they...
How has Globus Medical's stock price performed in 2022?
Globus Medical's stock was trading at $72.20 on January 1st, 2022. Since then, GMED stock has decreased by 18.2% and is now trading at $59.09. Vie...
Are investors shorting Globus Medical?
Globus Medical saw a increase in short interest in May. As of May 15th, there was short interest totaling 4,400,000 shares, an increase of 30.6% fr...
When is Globus Medical's next earnings date?
Globus Medical is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for Glob...
How were Globus Medical's earnings last quarter?
Globus Medical, Inc. (NYSE:GMED) released its quarterly earnings results on Tuesday, May, 10th. The medical device company reported $0.42 EPS for t...
What guidance has Globus Medical issued on next quarter's earnings?
Globus Medical updated its FY 2022 earnings guidance on Tuesday, June, 7th. The company provided earnings per share guidance of $2.10-$2.10 for the...
Who are Globus Medical's key executives?
Globus Medical's management team includes the following people: Mr. David C. Paul , Co-Founder & Exec. Chairman (Age 55, Pay $23.57k) Mr. Daniel...
What is David Demski's approval rating as Globus Medical's CEO?
47 employees have rated Globus Medical CEO David Demski on Glassdoor.com . David Demski has an approval rating of 61% among Globus Medical's emplo...
About Globus Medical
Headlines
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology.
Globus Medical (NYSE:GMED) Frequently Asked Questions
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?
What is Globus medical?
11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Globus Medical in the last year. There are currently 1 hold rating and 10 buy ratings for the stock.
Is Globus a publicly traded company?
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania.
New York Stock Exchange
Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders. Wikipedia.
Environmental, Social, and Governance Rating
This medical device company designs and sells products that alleviate spine disorders.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
What is Globus Medical?
This medical device company designs and sells products that alleviate spine disorders.
Is Globus Medical a platinum sponsor?
AUDUBON, Pa., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company , was recently awarded a group purchasing agreement with Premier, one of the ...
Is Globus Medical a big mover?
05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate as a platinum sponsor at the North Amer...
Signals & Forecast
Globus Medical (GMED) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Support, Risk & Stop-loss
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development.
Is Globus Medical Inc stock A Buy?
Globus Medical Inc finds support from accumulated volume at $64.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are positive buying more shares than they are selling in Globus Medical Inc
Globus Medical Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
About Globus Medical Inc
In the last 100 trades there were 1.46 million shares bought and 1.38 million shares sold. The last trade was done 27 days ago by Douglas Robert Andrew who bough 15 thousand shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Golden Star Signal
Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The company offers products that address an array of spinal pathologies, anatomies, and surgical approaches.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!